A Covid-19 vaccine manufacturing plant will be established in 2 years – Akufo Addo
President Nana Akufo-Addo said the government aims to build a national Covid-19 vaccine manufacturing plant within the next two years.
According to him, the factory would be used for the filling, finishing and packaging of Covid-19 vaccines and other vaccines.
He added that it would help “strengthen research and development for the production of vaccines”.
Speaking at a Covid-19 forum in Germany, President Akufo-Addo said Ghana was ready to help fight the pandemic on the African continent, hence the establishment of the local vaccine factory in Ghana.
This should be the first step in the national vaccine production chain, which will improve the supply of vaccines in Africa.
The vaccine production target follows a collaboration between Ghana, Senegal, Rwanda and German biotech company, BioNTech SE, to fill, finish and package BioNTech mRNA vaccines in Africa for the treatment of viruses as well as tuberculosis and malaria.
The agreement came after a meeting in Marburg, Germany, on Wednesday, where President Akufo-Addo, along with Presidents Macky Sall and Paul Kagame of the Republics of Senegal and Rwanda respectively, attended the presentation of a solution BioNtech modular production facility for the production of mRNA vaccines in Africa.
“I am going on February 16 with His Excellency, Mr. Macky Sall, President of the Republic of Senegal and His Excellency Mr. Paul Kagame, President of the Republic of Rwanda, to inspect in Marburg in Germany the production facilities that we must use for this purpose. .
“And then to build a pan-African project with these two brotherly African states where initially the filling and finishing plant will be located in Ghana,” Akufo-Addo said during the New Year’s school opening at the University of Ghana (UG).
The government also plans to invest $25 million as seed capital in the establishment of a National Vaccine Institute to lead the country’s efforts in local vaccine production.
The Institute will also work on vaccine research and development in Ghana, as well as developing a human resource base for vaccine discovery, development and manufacturing.
The establishment of the institute is one of the recommendations made by a government-appointed committee tasked with developing a concrete plan for the development and manufacture of vaccines in Ghana.
The Presidential Vaccine Manufacturing Committee has already indicated that Ghana would need $200 million to fully manufacture Covid-19 vaccines locally.